Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Macarthur

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Journal of Clinical Pharmacology|June 5, 2002
Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivityWilliam M O'Neil, Rodger D MacArthur, Marti J Farrough, et al.
HIV Clinical Trials|November 4, 2008
Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected personsMary van den Berg-Wolf, Katherine Huppler Hullsiek, Grace Peng, et al.
The New England Journal of Medicine|December 21, 1995
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working PartyJ J Eron, S L Benoit, J Jemsek, et al.
The Journal of Infectious Diseases|April 14, 2000
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853R D MacArthur, M M Lederman, C A Benson, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
Medical Science Educator|February 2, 2021
Adapting Education at the Medical College of Georgia at Augusta University in Response to the COVID-19 Pandemic: the Pandemic Medicine ElectiveJoseph Antony Elengickal, Amanda M Delgado, Shefali Priya Jain, et al.
AIDS (London, England)|December 20, 2007
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceEdward M Gardner, Shweta Sharma, Grace Peng, et al.
AIDS (London, England)|January 26, 2010
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trialEdward M Gardner, Katherine H Hullsiek, Edward E Telzak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2008
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individualsSharon B Mannheimer, Nicholas Wold, Edward M Gardner, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Journal of Clinical Pharmacology|June 5, 2002
Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivityWilliam M O'Neil, Rodger D MacArthur, Marti J Farrough, et al.
HIV Clinical Trials|November 4, 2008
Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected personsMary van den Berg-Wolf, Katherine Huppler Hullsiek, Grace Peng, et al.
The New England Journal of Medicine|December 21, 1995
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working PartyJ J Eron, S L Benoit, J Jemsek, et al.
The Journal of Infectious Diseases|April 14, 2000
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853R D MacArthur, M M Lederman, C A Benson, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
Medical Science Educator|February 2, 2021
Adapting Education at the Medical College of Georgia at Augusta University in Response to the COVID-19 Pandemic: the Pandemic Medicine ElectiveJoseph Antony Elengickal, Amanda M Delgado, Shefali Priya Jain, et al.
AIDS (London, England)|December 20, 2007
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistanceEdward M Gardner, Shweta Sharma, Grace Peng, et al.
AIDS (London, England)|January 26, 2010
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trialEdward M Gardner, Katherine H Hullsiek, Edward E Telzak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2008
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individualsSharon B Mannheimer, Nicholas Wold, Edward M Gardner, et al.
Pageof 16